1 / 8

Coexisting Conditions: Cancer and Cardiovascular Disease

Coexisting Conditions: Cancer and Cardiovascular Disease. Objectives. The learner will be able to: State the potential effects of having the coexisting conditions of cancer and cardiovascular (CV) disease. Discuss nursing implications of caring for a patient with both cancer and CV disease.

emma
Télécharger la présentation

Coexisting Conditions: Cancer and Cardiovascular Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coexisting Conditions:Cancer and Cardiovascular Disease

  2. Objectives The learner will be able to: • State the potential effects of having the coexisting conditions of cancer and cardiovascular (CV) disease. • Discuss nursing implications of caring for a patient with both cancer and CV disease.

  3. Cardiovascular Disease Overview • Refers to several types of heart conditions that can cause atherosclerosis • Includes a variety of cardiac, circulatory, or vascular problems • Leading cause of death in the U.S.; all ages and backgrounds can be affected. • Genetic conditions as well as some lifestyle factors can cause higher risk for CV disease. • Types of CV disease in the U.S.: • CAD resulting in myocardial infarction, angina, heart failure, arrhythmias • CVA, peripheral/arterial diseases, hyperlipidemia, hypertension

  4. Cardiovascular Disease Overview • Healthy People 2020 pledges to “improve cardiovascular health and quality of life through prevention, detection, and treatment of risk factors for heart attack and stroke; early identification and treatment of heart attacks and strokes; and prevention of repeat cardiovascular events.” • Currently 81 million annual deaths from heart disease in the U.S. • 14%17% of cancer survivors report having heart or circulation problems.

  5. Potential Impact • Both cancer and CV disease are prevalent diseases. • New specialty is emerging called cardio-oncology. • Risk factors: • Individual patient factors, including history of CV disease • Prior cancer treatment affecting chest and/or heart physiology • Drug interactions and contraindications are a possibility. • Exacerbation of preexisting symptoms related to specific types of CV disease may occur when certain cancer treatments are administered, depending on the actions and side effects of the treatment. • Anthracycline drugs and some targeted therapy agents have been shown to cause some degree of cardiotoxicity. • Consideration of the two conditions along with cancer need to be addressed pre-, during, and post-treatment.

  6. Impact Examples • Preexisting CV disease can affect dose, schedule, and type of cancer treatment administered. • Types of cardiotoxicity due to cancer treatments: • Direct cardiac effects and associated cardiac systolic dysfunction • Cardiac ischemia • Arrhythmias • Pericarditis • Drug-induced repolarization abnormalities • Result of cardiotoxic agents can include: • Decreased pump function • Cardiac ischemia • Arrhythmias • Pericarditis • QT wave prolongation.

  7. Nursing Care Implications • Prevention of heart failure is the optimal goal. • Good pretreatment assessment is imperative. • Stay updated to provide safe patient care as guidelines to prevent or minimize cardiotoxicity are developed. • Coexisting conditions of heart disease and cancer require nurses to: • Gather thorough health history data. • Obtain pretreatment laboratory results. • Assess baseline and monitor vital signs closely. • Ensure that baseline and periodic cardiac function testing is ordered and completed, and results are available (EKG, 2D-echo, MUGA scan). • Assess and manage baseline and ongoing symptoms related to all conditions. • Monitor cumulative doses of cardiotoxic agents. • Assist with collaboration efforts between physicians. • Promote cardiovascular self-management efforts.

  8. References American Heart Association. (2012). What is cardiovascular disease (heart disease)? Retrieved from http://www.heart.org/HEARTORG/Caregiver/Resources/WhatisCardiovascularDisease/What-is-Cardiovascular-Disease_UCM_301852_Article.jsp Edgington, A., & Morgan, M.A. (2011). Looking beyond recurrence: Comorbidities in cancer survivors. Clinical Journal of Oncology Nursing, 15, E3E12. doi:10.1188/11.CJON.E3-E12 Healthy People 2020. (2012). Heart disease and stroke. Retrieved from http://www.healthypeople.gov/2020/topicsobjectives2020/ebr.aspx?topicid=21 National Institutes of Health, Medline Plus. (2012). Heart diseases. Retrieved from http://www.nlm.nih.gov/medlineplus/heartdiseases.html Rosenbaum, E.H. (2009). Comorbid disease (chronic illnesses) from Cancer Supportive Survivorship Care. Retrieved from http://www.cancersupportivecare.com/Survivorship/comorbidity.html U.S. National Library of Medicine, PubMed Health. (2012). A.D.A.M. Medical Encyclopedia: Coronary heart disease. Retrieved from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004449/

More Related